Searched for
INTRANASAL VACCINE
On January 26, India's first COVID intranasal vaccination iNCOVACC will go on saleiNCOVACC, a brand-new domestic drug, has been introduced by Bharat Biotech to aid in the fight against COVID 19. The nasal Covid vaccine ha...- Govt may not procure Bharat Biotech's intranasal Covid vaccine iNNOVACCBharat Biotech has made its intranasal Covid-19 vaccine iNNOVACC available on CoWin, priced at ₹800 per dose for private markets and ₹325 f...
- Bharat Biotech's intranasal vaccine Incovacc to debut on Co-WinThis is the world's first intranasal vaccine for Covid-19 to receive approval for the primary 2-dose schedule, and as a heterologous booste...
- Bharat Biotech’s intranasal vaccine ‘iNCOVACC’ receives CDSCO approval under restricted useThe Central Drugs Standard Control Organisation (CDSCO) gave its nod to the vaccine for use as both primary series as well as a heterologou...
- SEC to review Bharat Bio's intranasal jab for use as booster soonCovaxin - and has submitted the data to the Drugs Controller General of India (DCGI) for the review. Hyderabad based Bharat Biotech has sou...
- Bharat Biotech seeks DCGI nod for phase-3 study of intranasal Covid vaccine in 5-18 age groupiNCOVACC is a recombinant replication deficient adenovirus vectored vaccine with a pre-fusion stabilised spike protein. This vaccine candid...
- Bharat Biotech seeks nod for intranasal Covid vaccineAccording to the vaccine maker, it conducted two separate and simultaneous clinical trials to evaluate its intranasal vaccine (BBV154) as a...
- Submitted data for approval of intranasal vaccine to drug regulator: Bharat BiotechAccording to the vaccine maker, it conducted two separate and simultaneous clinical trials to evaluate its intranasal vaccine (BBV154) as a...
- NTAGI may soon review efficacy data of India's first intranasal Covid vaccineThe date of the meeting is yet to be fixed. India's drug controller had in January this year given permission to Bharat Biotech to conduct ...
- No more jabs: Nasal Covid vaccines may be the future as they treat the infection right where it startsNasal vaccines are administered, as the name suggests, through the nose.
- Bharat Biotech gets nod for nasal Covid-19 vaccine's phase-3 clinical trials"Intranasal vaccines are easier to administer in mass immunisation campaigns and help reduce/stop transmission," the company said in a stat...
- DCGI allows Bharat Biotech to conduct phase-3 trials for Covid's intranasal booster doseThe trials of the Intranasal vaccine will take place at nine different sites of the country.
- Bharat Biotech asked to conduct Phase III trials for its intranasal vaccineThe company had also sought approval from the SEC to use its intranasal vaccine as a booster dose, to which the SEC asked the company to su...
- Bharat Biotech seeks nod for phase-3 trials of intranasal COVID-19 vaccine as booster doseAn intranasal vaccine as a booster dose would be easier to administer in mass vaccination campaigns and has the potential to prevent transm...
- Bharat Bio hopes to soon submit trial data for intranasal vaccine"The trials are ongoing, and we expect to submit data by the end of this year," a company insider said. The trials, including over 600 part...
- Bharat Biotech gets nod for Phase 2/3 trials of intranasal Covid vaccineBBV154 is the first intranasal Covid-19 vaccine to undergo human trials in India. It has now received approval to conduct Phase 2 randomise...
- Bharat Biotech's Covid nasal vaccine gets regulator's nod for holding phase 2 clinical trialEarly stage trials of the vaccine candidate, BBV154, has been completed in subjects aged 18 to 60 years, and the doses were found to be wel...
- Expert panel recommends permission for phase 1 clinical trial of Bharat Biotech's nasal vaccine"Based on the safety and immunogenicity data of the phase 1 clinical trial, the company would be given permission for conducting phase 2 cl...
- Bharat Biotech's intranasal vaccine to enter phase I/II trials by month-endVaccine producer Bharat Biotech International (BBIL) could begin phase I/II human clinical trials for its single-dose intranasal vaccine ca...
- Bharat Biotech inks pact with WU's School of Medicine for COVID-19 intranasal vaccineIn a statement on Wednesday, the biotechnology company said it owns the rights to distribute the vaccine in all markets except the US, Japa...
Load More
